Biotechnology firms depend on their intellectual property rights. Some firms manage large patent portfolios to monetize their intellectual property, while others rely on out-licensing their IP. Regardless of the strategy and scope, IP rights are crucial if you want to create a successful business offering Life Science products.

Developing a Life Science product requires substantial investments and a whole lot of time. If entrepreneurs develop products without developing a strong IP strategy and ensuring proper patent protection, they create a huge capital risk. The best way to protect your capital and pave the way for future investments is by protecting your products and securing freedom to operate,” says Christian L. Christiansen, European patent attorney and a Partner at Plougmann Vingtoft.

READ ALSO: Strong IP Strategy Ensures Investor Capital for Danish Biotech Firm

Protecting biotechnology inventions requires updated knowledge on patent case law and a good overview of existing IP rights.

Plougmann Vingtoft’s team of Life Science experts have vast experience in helping biotech firms protect their ideas. You are welcome to contact one of the experts listed below for more information on patenting of biotechnology.

Alternatively, you can fill this contact form with your inquiry and we will get back to you as soon as possible.